You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

avastin refractory

Showing 1 - 25 of 9,349
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

Not yet recruiting
  • Glioblastoma Multiforme
  • +4 more
  • SIACI of cetuximab and bevacizumab
  • Miami, Florida
    Jackson Memorial Hospital
Jul 14, 2023

Trifluridine/Tipiracil Plus Bevacizumab Versus

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
May 11, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • New York, New York
    Lenox Hill Brain Tumor Center
Nov 10, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New Haven, Baltimore (Ixabepilone,

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • New Haven, Connecticut
  • +1 more
Jan 11, 2023

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Completed
Has Results
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Bevacizumab
  • Irinotecan Sucrosofate
  • Chicago, Illinois
    Northwestern University
Dec 21, 2022

Solid Tumor, Colorectal Cancer, Gastric Cancer Trial in United States (IGM-8444, FOLFIRI, Bevacizumab (and approved

Recruiting
  • Solid Tumor
  • +7 more
  • Duarte, California
  • +11 more
Jan 6, 2023

Neuroblastoma Trial in Worldwide (Bevacizumab, Temozolomide, Irinotecan)

Active, not recruiting
  • Neuroblastoma
  • Vienna, Austria
  • +9 more
Feb 14, 2022

Intracranial Meningioma Trial in United States (Everolimus, Bevacizumab)

Terminated
Has Results
  • Intracranial Meningioma
  • Orlando, Florida
  • +6 more
Nov 8, 2021

Solid Tumor Trial in Cincinnati (Bevacizumab, Temozolomide, Vincristine)

Completed
  • Solid Tumor
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Feb 8, 2021

Germ Cell Tumor Trial in Minneapolis (Brentuximab Vedotin, Bevacizumab)

Terminated
Has Results
  • Germ Cell Tumor
  • Minneapolis, Minnesota
    University of Minnesota
Nov 12, 2020

Glioblastoma, Glioma, Gliosarcoma Trial in United States (Bevacizumab, TTFields Therapy)

Terminated
Has Results
  • Glioblastoma
  • +2 more
  • La Jolla, California
  • +10 more
May 12, 2021

Metastatic Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Refractory Colorectal Carcinoma Trial in United States (drug,

Active, not recruiting
Has Results
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Phoenix, Arizona
  • +9 more
Jan 5, 2022

Brain Cancer, Pediatric Cancers Trial in United States (Bevacizumab, Lapatinib)

Completed
Has Results
  • Brain Cancer
  • Pediatric Cancers
  • Stanford, California
  • +5 more
Aug 14, 2020

Unspecified Adult Solid Tumor Trial in San Francisco (bevacizumab, cyclophosphamide, imatinib)

Completed
  • Unspecified Adult Solid Tumor
  • bevacizumab
  • +2 more
  • San Francisco, California
    UCSF Helen Diller Family Comprehensive Cancer Center
Jul 24, 2020

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Active, not recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +7 more
  • Anetumab Ravtansine
  • +2 more
  • Orange, California
  • +22 more
Oct 22, 2022

Ovarian Tumors, Fallopian Tube Tumors, Endocrine Gland Tumors Trial in Nanjing (Niraparib, Bevacizumab)

Unknown status
  • Ovarian Neoplasms
  • +23 more
  • Nanjing, Jiangsu, China
    JiangSu Cancer Hospital
Nov 8, 2020

Glioblastoma Multiforme Trial in United States (Bevacizumab, BKM120)

Completed
Has Results
  • Glioblastoma Multiforme
  • New Haven, Connecticut
  • +7 more
Jun 8, 2020

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 Trial in United States (biological, drug, other)

Completed
Has Results
  • Colorectal Adenocarcinoma
  • +4 more
  • Bevacizumab
  • +4 more
  • Scottsdale, Arizona
  • +12 more
Jan 27, 2022

Ovarian Cancer Trial in Albuquerque, New York (Doxil, Bevacizumab (Avastin))

Completed
  • Ovarian Cancer
  • Albuquerque, New Mexico
  • +3 more
Sep 26, 2019

Tumors Trial run by the NCI (Bevacizumab, BAY 43-9006)

Completed
  • Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Refractory Metastatic Colorectal Cancer Trial in Worldwide (Trifluridine/Tipiracil, Bevacizumab)

Active, not recruiting
  • Refractory Metastatic Colorectal Cancer
  • Phoenix, Arizona
  • +102 more
Apr 4, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Astrocytoma, Brain Cancer, Brain Metastases Trial in Kogarah, Liverpool (QBS10072S)

Recruiting
  • Astrocytoma
  • +22 more
  • Kogarah, New South Wales, Australia
  • +1 more
Apr 18, 2022